Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


GeoVax, Inc. 

Press releases archived for reference only.
1256 Briarcliff Road
Atlanta  Georgia  30306  U.S.A.
Phone: Fax:


 Company News
GeoVax Labs Inc. (GOVX.OB) DNA/MVA Vaccine Elicits Sustained Antibody Responses to HIV 10/9/2013 10:31:13 AM
GeoVax Labs Inc. (GOVX.OB) Reports Financial Results for the Second Quarter and First Half 2013 and Provides Clinical Development Update 8/13/2013 9:18:22 AM
GeoVax Labs Inc. (GOVX.OB) Announces Enrollment Completion for Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine 1/10/2013 8:57:28 AM
GeoVax Labs Inc. (GOVX.OB) to Present at Fifth Annual LD Micro Conference 11/29/2012 9:09:28 AM
GeoVax Labs Inc. (GOVX.OB) Reports 2012 Second Quarter Financial Results 8/13/2012 8:57:24 AM
GeoVax, Inc. to Attend Biotechnology Industry Organization (BIO) International Convention June 18-21 in Boston 6/11/2012 9:44:07 AM
GeoVax, Inc. Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial 12/7/2010 7:20:26 AM
GeoVax, Inc. Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program 11/5/2010 6:57:09 AM
GeoVax, Inc. Presents at AIDS Vaccine 2010 Conference in Atlanta 10/1/2010 9:31:05 AM
GeoVax, Inc. to Present at HIV/AIDS Vaccine Symposium at New York Academy of Sciences on May 19 5/17/2010 11:47:15 AM